RSS

spin-off

Clinical stage biotech company, Minoryx Therapeutics, has revealed it is spinning off its Site-directed Enzyme Enhancement Therapy (SEE-Tx) platform into a new company, Gain Therapeutics more

Technology

Biovest is to separate its instrument and contract manufacturing offerings into a single subsidiary, Cell Culture Company, which will focus on bioreactors and bioservice solutions more

News